The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension

Summary

The purpose of this clinical study is to evaluate and compare the efficacy and safety of Fimasartan (60mg / 120mg) with Candesartan(8mg) in patients with mild to moderate hypertension.

Conditions

• Hypertension

Interventions

DRUG

Fimasartan 60mg

Fimasartan 60mg for mild to moderate hypertension. Take a tablet(filled in Doubleblind capsule) every morning.

DRUG

Fimasartan 120mg

Fimasartan 120mg for mild to moderate hypertension. Take a tablet(filled in Doubleblind capsule) every morning.

DRUG

Candesartan cilexetil

Candesartan 8mg for mild to moderate hypertension. Take a tablet(filled in Doubleblind capsule) every morning.

Sponsors & Collaborators

• Kyungpook National University Hospital

  collaborator OTHER

• Gyeongsang National University Hospital

  collaborator OTHER

• Keimyung University

  collaborator OTHER

• Kosin University Gospel Hospital

  collaborator OTHER

• Daegu Catholic University Medical Center

  collaborator OTHER

• Dong-A medical center

  collaborator UNKNOWN

• Pusan National University Yangsan Hospital

  collaborator OTHER

• Yeungnam University Hospital

  collaborator OTHER

• Ulsan University Hospital

  collaborator OTHER

• Inje University

  collaborator OTHER

• Pusan National University Hospital

  collaborator OTHER

• Boryung Pharmaceutical Co., Ltd

  lead INDUSTRY

Principal Investigators

• ShungChull Chae, Doctor´s degree · KuyngPook National Hospital

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Model

PARALLEL

Eligibility

Min Age

19 Years

Max Age

75 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2010-04-30

Primary Completion

2011-04-30

Completion

2011-05-31

Countries

• South Korea

Study Locations